Clinical Trials
All Clinical Trials - Page 20 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT05751226Phase 1Completed
A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906
Semaglutide
- NCT05815680Phase 1Completed
A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
Mazdutide
- NCT05564104Phase 1Completed
A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the Body
Cagrilintide
- NCT05810597Phase 1Completed
A Research Study Looking at Similarity Between Tirzepatide Versions for Different Injection Devices
Tirzepatide
- NCT05813925Phase 3Completed
A Research Study to See How Well CagriSema Helps People in East Asia With Excess Body Weight Lose Weight
Semaglutide
- NCT05803421Phase 3Completed
A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
Orforglipron
- NCT05790447Phase 2Unknown
Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors
Thymosin-Alpha-1
- NCT06217770N/ACompleted
Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment
Gonadorelin
- NCT05390307N/ACompleted
Obesity Treatment to Improve Diabetes
Semaglutide
- NCT06827002Phase 1/Phase 2Active Not Recruiting
Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults
Semaglutide
- NCT05854784Phase 2Completed
Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)
Afamelanotide
- NCT05359146EARLY_Phase 1Unknown
Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3)
Octreotide
- NCT05937490Phase 4Unknown
Adenomyosis and ART
Gonadorelin
- NCT05586802Phase 3Recruiting
Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome
Semaglutide
- NCT05794581Phase 1Completed
A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants with Type 1 Diabetes
Liraglutide
- NCT05757531Phase 1Completed
A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants
Retatrutide
- NCT05784402Phase 1Completed
A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participants
Semaglutide
- NCT05767086N/ACompleted
Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles
Gonadorelin
- NCT05441267Phase 4Active Not Recruiting
A Study of Cardiovascular Events iN Diabetes Plus
Semaglutide
- NCT05443568N/ACompleted
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice
Semaglutide
- NCT05706506Phase 4Completed
A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)
Tirzepatide
- NCT05169112Phase 3Recruiting
Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy
Gonadorelin
- NCT05761431Phase 1Completed
A Single-dose Study of Octreotide Injection in Healthy Adult Subjects
Octreotide
- NCT05669755Phase 3Active Not Recruiting
REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
Semaglutide
- NCT05649943N/ARecruiting
Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment
Gonadorelin
- NCT05502562N/ACompleted
A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
Semaglutide
- NCT05779644N/AUnknown
Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
Semaglutide
- NCT05622123Phase 2Unknown
BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
Exenatide
- NCT05607004Phase 2Active Not Recruiting
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Ghrp-6
- NCT07272343Phase 4Recruiting
The Impact of Semaglutide Compared to Energy Restriction on Type 2 Diabetes
Semaglutide
- NCT05536804Phase 2Active Not Recruiting
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Tirzepatide
- NCT05501483N/ARecruiting
Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes
Semaglutide
- NCT05696847Phase 1Completed
A Study of Tirzepatide (LY3298176) in Pediatric Participants With Obesity
Tirzepatide
- NCT05691712Phase 3Completed
A Study of Tirzepatide (LY3298176) in Chinese Participants With Type 2 Diabetes
Tirzepatide
- NCT05896293Phase 2Recruiting
Kisspeptin Administration Subcutaneously to Patients With IHH
Kisspeptin
- NCT05982093Phase 2Recruiting
Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
Gonadorelin
- NCT05622045N/AActive Not Recruiting
Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)
Semaglutide
- NCT05394519Phase 3Completed
A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
Semaglutide
- NCT05610124N/AUnknown
Postprandial Glycemia and Satiety of Meals With Potatoes, With and Without Protein
Ghrp-6
- NCT05498272Phase 2Active Not Recruiting
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations
Gonadorelin
- NCT07340437N/ACompleted
Clinical Study of 18F-Exendin-4 in Insulinoma
Exenatide
- NCT05605964Phase 3Completed
Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate
Gonadorelin
- NCT06607666N/ACompleted
Acromegaly Resistant to Conventional Dose of First Generation Somatostatin Ligands
Lanreotide
- NCT05716724N/ACompleted
O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait
Semaglutide
- NCT05579249Phase 4Completed
A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America
Semaglutide
- NCT05671653Phase 1Terminated
A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range
Semaglutide
- NCT05669599Phase 2Completed
Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus
Maridebart-Cafraglutide
- NCT05689099Phase 1Completed
A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose
Semaglutide
- NCT05705388N/AUnknown
POSE2.0 With GLP-1 Agonist for Obesity Management
Liraglutide
- NCT04915144Phase 2Withdrawn
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs
Octreotide